TrialBlood advances2021

Adding venetoclax to fludarabine/busulfan RIC transplant for high-risk MDS and AML is feasible, safe, and active.

Jacqueline S Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.